Ozempic 4 mm Needle Failed to Deliver the First Dose

I started using Ozempic after receiving approval from my doctor. I weigh 90 kg and have a body mass index (BMI) above 30. I administered my first dose of 0.25 mg into my abdominal area; however, the injection could not be performed properly because the 4 mm needle tip was apparently insufficient, causing the medication to leak onto my skin and go to waste.

I later learned that a needle tip of at least 6 mm is reportedly required. However, this critical information about needle length is not clearly stated in the product leaflet. The omission of such important instructions has caused me significant inconvenience, both in terms of my health and the loss of medication that I need for my treatment.

Today, I reported the issue to Novo Nordisk, explaining the problem I experienced and requesting clear information about the appropriate needle length. However, the company merely stated that it had registered an adverse event report and failed to provide any meaningful clarification regarding my questions about 4 mm and 6 mm needle tips. Neither was my wasted medication compensated for, nor was I given a satisfactory explanation.

I am requesting that the inconvenience I experienced from the very first dose of this treatment, which I need to continue using, be properly addressed, that the wasted medication be replaced or compensated for, and that the Ozempic patient information leaflet be updated to provide clear, explicit, and unambiguous instructions regarding needle length so that patients are not misled or left without essential information.

Comments